Market Overview:
The Global Jet Lag Therapy Pharmaceuticals Market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing number of business travelers, cabin crew, athletes, and seasonal travelers across the globe. Additionally, rising awareness about jet lag therapy pharmaceuticals and their benefits is also propelling the market growth. However, stringent regulatory norms for product approvals are restraining the market growth to some extent. Based on type, Rx products accounted for a major share of the global jet lag therapy pharmaceuticals market in 2017. This can be attributed to their high efficacy in treating jet lag symptoms as compared to OTC products. However, OTC products are witnessing a higher CAGR owing to their easy availability and affordability as compared to Rx products. Based on application, business travelers held a dominant share of the global jet lag therapy pharmaceuticals market in 2017; this segment is projected witness highest CAGR during 2018-2030 owing growing number of business trips across different geographies worldwide .
Product Definition:
Jet Lag Therapy Pharmaceuticals is a medication used to help people adjust to changes in time zones. It can help reduce the symptoms of jet lag, including fatigue, irritability, and difficulty concentrating.
Rx:
Rx is a colloquial term used to define the medication or drug that is being prescribed for a patient by a doctor. In most cases, an Rx refers to an OTC (over the counter) medicine that can be purchased without a prescription. However, in other cases, such as with some pain medications and anti-inflammatory drugs, it may require a prescription from your physician.
OTC:
OTC stands for Over The Counter and it is a term used for drugs which are sold without prescription. OTC products are usually easy to use, more convenient, and affordable compared to prescription medicines. OTC products also have less or no side effects unlike prescription medicines which makes them safer to use.
The global OTC market was valued at USD 65 billion in 2015.
Application Insights:
The others segment held the largest share of over 50.0% in 2017. The others segment includes patients who are not traveling for work or leisure but require treatment on a regular basis due to other health issues.jet lag therapy pharmaceuticals are widely used by athletes and sportspersons travelling across different parts of the world as it helps them perform at their optimum level by regulating body clocks thus improving performance and stamina during training and competition. Cabin crew is expected to be one of the fastest-growing segments owing to increasing air travel demand, especially for business travelers flying long-distance between countries with different time zones, which results in an unbalanced schedule that can potentially lead to various health problems including fatigue, insomnia, irritability and loss of appetite among other symptoms.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of airline companies and high airfares due to increased demand and low supply are some of the factors driving this regional market. Moreover, technological advancements such as live chat support, online booking services, mobile apps for travel management etc., on-board entertainment systems installed with lullabies or white noise are also contributing towards higher sales in this region.
Asia Pacific is expected to be one of the fastest growing regions over the forecast period owing to increasing business travelers across emerging economies including China and India along with other South East Asian countries such as Singapore, Thailand etc., which will drive product demand in this region. In addition, increasing awareness about jet lag therapy among cabin crew members is anticipated to fuel growth during the forecast period.
Growth Factors:
- Increasing awareness about the benefits of Jet Lag Therapy Pharmaceuticals among people.
- Rising disposable income of people, which will help in increased adoption of Jet Lag Therapy Pharmaceuticals.
- Growing demand for preventive healthcare services, which is expected to fuel the growth of the Jet Lag Therapy Pharmaceuticals market in the coming years.
- Technological advancements in Jet Lag Therapy Pharmaceuticals products and increasing R&D investments by key players are likely to boost the growth of this market in future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Jet Lag Therapy Pharmaceuticals Market Research Report
By Type
Rx, OTC
By Application
Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others
By Companies
Teva, Natrol/Aurobindo, Pharmavite, Nature's Bounty, Jameison, Pfizer, Now Food
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Jet Lag Therapy Pharmaceuticals Market Report Segments:
The global Jet Lag Therapy Pharmaceuticals market is segmented on the basis of:
Types
Rx, OTC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Natrol/Aurobindo
- Pharmavite
- Nature's Bounty
- Jameison
- Pfizer
- Now Food
Highlights of The Jet Lag Therapy Pharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rx
- OTC
- By Application:
- Business Travelers
- Cabin Crew
- Athletes
- Seasonal Travelers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Jet Lag Therapy Pharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Jet Lag Therapy Pharmaceuticals is a company that manufactures and sells products to treat jet lag. The company's products include over-the-counter medications, supplements, and sleep aids.
Some of the key players operating in the jet lag therapy pharmaceuticals market are Teva, Natrol/Aurobindo, Pharmavite, Nature's Bounty, Jameison, Pfizer, Now Food.
The jet lag therapy pharmaceuticals market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Jet Lag Therapy Pharmaceuticals Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Jet Lag Therapy Pharmaceuticals Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Jet Lag Therapy Pharmaceuticals Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Jet Lag Therapy Pharmaceuticals Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Jet Lag Therapy Pharmaceuticals Market Size & Forecast, 2018-2028
4.5.1 Jet Lag Therapy Pharmaceuticals Market Size and Y-o-Y Growth
4.5.2 Jet Lag Therapy Pharmaceuticals Market Absolute $ Opportunity
Chapter 5 Global Jet Lag Therapy Pharmaceuticals Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Jet Lag Therapy Pharmaceuticals Market Size Forecast by Type
5.2.1 Rx
5.2.2 OTC
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Jet Lag Therapy Pharmaceuticals Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Jet Lag Therapy Pharmaceuticals Market Size Forecast by Applications
6.2.1 Business Travelers
6.2.2 Cabin Crew
6.2.3 Athletes
6.2.4 Seasonal Travelers
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Jet Lag Therapy Pharmaceuticals Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Jet Lag Therapy Pharmaceuticals Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Jet Lag Therapy Pharmaceuticals Analysis and Forecast
9.1 Introduction
9.2 North America Jet Lag Therapy Pharmaceuticals Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Jet Lag Therapy Pharmaceuticals Market Size Forecast by Type
9.6.1 Rx
9.6.2 OTC
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Jet Lag Therapy Pharmaceuticals Market Size Forecast by Applications
9.10.1 Business Travelers
9.10.2 Cabin Crew
9.10.3 Athletes
9.10.4 Seasonal Travelers
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Jet Lag Therapy Pharmaceuticals Analysis and Forecast
10.1 Introduction
10.2 Europe Jet Lag Therapy Pharmaceuticals Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Jet Lag Therapy Pharmaceuticals Market Size Forecast by Type
10.6.1 Rx
10.6.2 OTC
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Jet Lag Therapy Pharmaceuticals Market Size Forecast by Applications
10.10.1 Business Travelers
10.10.2 Cabin Crew
10.10.3 Athletes
10.10.4 Seasonal Travelers
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Jet Lag Therapy Pharmaceuticals Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Jet Lag Therapy Pharmaceuticals Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Jet Lag Therapy Pharmaceuticals Market Size Forecast by Type
11.6.1 Rx
11.6.2 OTC
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Jet Lag Therapy Pharmaceuticals Market Size Forecast by Applications
11.10.1 Business Travelers
11.10.2 Cabin Crew
11.10.3 Athletes
11.10.4 Seasonal Travelers
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Jet Lag Therapy Pharmaceuticals Analysis and Forecast
12.1 Introduction
12.2 Latin America Jet Lag Therapy Pharmaceuticals Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Jet Lag Therapy Pharmaceuticals Market Size Forecast by Type
12.6.1 Rx
12.6.2 OTC
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Jet Lag Therapy Pharmaceuticals Market Size Forecast by Applications
12.10.1 Business Travelers
12.10.2 Cabin Crew
12.10.3 Athletes
12.10.4 Seasonal Travelers
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Jet Lag Therapy Pharmaceuticals Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Jet Lag Therapy Pharmaceuticals Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Jet Lag Therapy Pharmaceuticals Market Size Forecast by Type
13.6.1 Rx
13.6.2 OTC
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Jet Lag Therapy Pharmaceuticals Market Size Forecast by Applications
13.10.1 Business Travelers
13.10.2 Cabin Crew
13.10.3 Athletes
13.10.4 Seasonal Travelers
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Jet Lag Therapy Pharmaceuticals Market: Competitive Dashboard
14.2 Global Jet Lag Therapy Pharmaceuticals Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Natrol/Aurobindo
14.3.3 Pharmavite
14.3.4 Nature's Bounty
14.3.5 Jameison
14.3.6 Pfizer
14.3.7 Now Food
